Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma

by Robert A. Belderbos, Robert A. Belderbos, Heleen Vroman, Heleen Vroman, Joachim G. J. V. Aerts, Joachim G. J. V. Aerts
Published 2020-06-01

Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?

by Anne Huber, Floris Dammeijer, Floris Dammeijer, Joachim G. J. V. Aerts, Joachim G. J. V. Aerts, Heleen Vroman, Heleen Vroman
Published 2018-12-01

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?

by Luca Cantini, Luca Cantini, Luca Cantini, Raffit Hassan, Daniel H. Sterman, Joachim G. J. V. Aerts, Joachim G. J. V. Aerts
Published 2020-03-01

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment

by Robert A. Belderbos, Joachim G.J.V. Aerts, Heleen Vroman
Published 2019-06-01

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

by Mandy van Gulijk, Mandy van Gulijk, Floris Dammeijer, Floris Dammeijer, Joachim G. J. V. Aerts, Joachim G. J. V. Aerts, Heleen Vroman, Heleen Vroman
Published 2018-12-01

A Patient with Four-Year Survival after Nonsmall Cell Lung Carcinoma with a Solitary Metachronous Small Bowel Metastasis

by Klaas M. Kant, Vincent Noordhoek Hegt, Joachim G. J. V. Aerts
Published 2010-01-01

Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials

by Daphne W. Dumoulin, Robin Cornelissen, Koen Bezemer, Sara J. Baart, Joachim G. J. V. Aerts
Published 2021-05-01

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis

by Rute M. S. M. Pedrosa, Dana A. M. Mustafa, Joachim G. J. V. Aerts, Johan M. Kros
Published 2018-05-01

Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two c...

by Joanne M. Mankor, Maria J. Disselhorst, Myrthe Poncin, Paul Baas, Joachim G.J.V. Aerts, Heleen Vroman
Published 2020-12-01

Iron deficiency anemia as initial presentation of a non-small cell lung carcinoma: A case report

by Philip V.M. Linsen, Victor M.J. Linsen, Gerba Buunk, Dorothee E. Arnold, Joachim G.J.V. Aerts
Published 2015-01-01

Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in a...

by Mark de Mol, Sabine Visser, Joachim G. J. V. Aerts, Paul Lodder, Jolanda de Vries, Brenda L. den Oudsten
Published 2018-11-01

Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC

by Luca Cantini, Federica Pecci, Filippo Merloni, Andrea Lanese, Edoardo Lenci, Francesco Paoloni, Joachim G.J.V. Aerts, Rossana Berardi
Published 2021-02-01

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

by Niken M. Mahaweni, Margaretha E.H. Kaijen-Lambers, Jacqueline Dekkers, Joachim G.J.V. Aerts, Joost P.J.J. Hegmans
Published 2013-10-01

In Response to “Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting”

by Robert A. Belderbos, MD, Joachim G.J. V. Aerts, MD, PhD, Jan H. von der Thüsen, MD, PhD
Published 2021-09-01

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial

by James D. Chalmers, Remco S. Djamin, Marjolijn Schouten, Holly R. Keir, Brandon Tan, Joachim G.J.V. Aerts, Jeffrey T-J. Huang, Menno van der Eerden
Published 2018-11-01

Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis

by Deirdre M.H.J. ten Berge, Daniel P. Hurkmans, Ilse den Besten, Jeroen S. Kloover, Ron H.J. Mathijssen, Reno Debets, Egbert F. Smit, Joachim G.J.V. Aerts
Published 2019-12-01

Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS

by Pauline L. de Goeje, Pauline L. de Goeje, Yarne Klaver, Yarne Klaver, Margaretha E. H. Kaijen-Lambers, Margaretha E. H. Kaijen-Lambers, Anton W. Langerak, Heleen Vroman, Heleen Vroman, André Kunert, André Kunert, André Kunert, Cor H. J. Lamers, Cor H. J. Lamers, Joachim G. J. V. Aerts, Joachim G. J. V. Aerts, Reno Debets, Reno Debets, Rudi W. Hendriks
Published 2018-09-01

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

by Joris D. Veltman, Margaretha E. H. Lambers, Menno van Nimwegen, Sanne de Jong, Rudi W. Hendriks, Henk C. Hoogsteden, Joachim G. J. V. Aerts, Joost P. J. J. Hegmans
Published 2010-01-01

Evaluation of a Home Monitoring Application for Follow Up after Lung Transplantation—A Pilot Study

by Nynke Wijbenga, Rogier A. S. Hoek, Bas J. Mathot, Leonard Seghers, Jan J. van Weezel, José den Ouden, Marlies S. Wijsenbeek, Joachim G. J. V. Aerts, Merel E. Hellemons, Catharina C. Moor
Published 2020-11-01

Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based i...

by Lisanne Noordam, Margaretha E.H. Kaijen, Koen Bezemer, Robin Cornelissen, Lex A.P.W.M. Maat, Henk C. Hoogsteden, Joachim G.J.V. Aerts, Rudi W. Hendriks, Joost P.J.J Hegmans, Heleen Vroman
Published 2018-12-01